Type 2 Diabetes Mellitus Trajectories and Associated Risks.

作者: Wonsuk Oh , Era Kim , M. Regina Castro , Pedro J. Caraballo , Vipin Kumar

DOI: 10.1089/BIG.2015.0029

关键词:

摘要: Disease progression models, statistical models that assess a patient's risk of diabetes progression, are popular tools in clinical practice for prevention and management chronic conditions. Most, if not all, currently use based on gold standard trial data. The relatively small sample size available from limits these only considering the state at time assessment ignoring trajectory, sequence events, led up to state. Recent advances adoption electronic health record (EHR) systems large they contain have paved way build disease can take trajectories into account, leading increasingly accurate personalized assessment. To address problems, we present novel method observe directly. We demonstrate effectiveness proposed by studying type 2 mellitus (T2DM) trajectories. Specifically, using EHR data population-based cohort, identified typical trajectory most people follow, which is diseases hyperlipidemia (HLD) hypertension (HTN), impaired fasting glucose (IFG), T2DM. In addition, also show patients who follow different face significantly increased or decreased risk.

参考文章(12)
D. M. Eddy, L. Schlessinger, Archimedes: a trial-validated model of diabetes. Diabetes Care. ,vol. 26, pp. 3093- 3101 ,(2003) , 10.2337/DIACARE.26.11.3093
Peter WF Wilson, James B Meigs, Lisa Sullivan, Caroline S Fox, David M Nathan, Ralph B D’Agostino, Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study JAMA Internal Medicine. ,vol. 167, pp. 1068- 1074 ,(2007) , 10.1001/ARCHINTE.167.10.1068
Christopher D. Saudek, Can Diabetes Be Cured? JAMA. ,vol. 301, pp. 1588- 1590 ,(2009) , 10.1001/JAMA.2009.508
Walter A. Rocca, Barbara P. Yawn, Jennifer L. St. Sauver, Brandon R. Grossardt, L. Joseph Melton, History of the Rochester Epidemiology Project: Half a Century of Medical Records Linkage in a US Population Mayo Clinic Proceedings. ,vol. 87, pp. 1202- 1213 ,(2012) , 10.1016/J.MAYOCP.2012.08.012
P. M. Clarke, A. M. Gray, A. Briggs, A. J. Farmer, P. Fenn, R. J. Stevens, D. R. Matthews, I. M. Stratton, R. R. Holman, , A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) Diabetologia. ,vol. 47, pp. 1747- 1759 ,(2004) , 10.1007/S00125-004-1527-Z
J. B. Buse, S. Caprio, W. T. Cefalu, A. Ceriello, S. Del Prato, S. E. Inzucchi, S. McLaughlin, G. L. Phillips, R. P. Robertson, F. Rubino, R. Kahn, M. S. Kirkman, How Do We Define Cure of Diabetes Diabetes Care. ,vol. 32, pp. 2133- 2135 ,(2009) , 10.2337/DC09-9036
A. N. Kho, J. A. Pacheco, P. L. Peissig, L. Rasmussen, K. M. Newton, N. Weston, P. K. Crane, J. Pathak, C. G. Chute, S. J. Bielinski, I. J. Kullo, R. Li, T. A. Manolio, R. L. Chisholm, J. C. Denny, Electronic Medical Records for Genetic Research: Results of the eMERGE Consortium Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3001807
Josephine M. Forbes, Mark E. Cooper, Mechanisms of Diabetic Complications Physiological Reviews. ,vol. 93, pp. 137- 188 ,(2013) , 10.1152/PHYSREV.00045.2011